Conditions: Cystic Fibrosis
Intervention Type: Drug
Intervention Name: tobramycin
Clinical Trials
The following are clinical trials from the Healia Clinical Trials Information Database that are researching the effect of the "Drug" intervention "tobramycin" on "Cystic Fibrosis".
-
Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis
NCTID: NCT00004829
-
A Multicentre, Multinational, Open-Label, Randomised, Parallel Group Clinical Trial of Tobrineb��/Actitob��/Bramitob�� (Tobramycin Solution for Nebulisation, 300mg Twice Daily in 4mL Unit Dose Vials) Compared to TOBI�� in the Treatment of Patients With Cystic Fibrosis and Chronic Infection With Pseudomonas Aeruginosa
NCTID: NCT00885365
-
A Single Arm 48-Week Follow-on Safety Study to the Core Study (A Multicentre, Multinational, Open-Label, Randomised, Parallel Group Clinical Trial of Tobrineb��/Actitob��/Bramitob�� (Tobramycin Solution for Nebulisation, 300mg Twice Daily in 4mL Unit Dose Vials) Compared to TOBI�� in the Treatment of Patients With Cystic Fibrosis and Chronic Infection With Pseudomonas Aeruginosa)
NCTID: NCT01111383